Pharmacotherapeutic considerations in anesthesia Journal Article
| Authors: | Goldstein, S.; Amar, D. |
| Article Title: | Pharmacotherapeutic considerations in anesthesia |
| Abstract: | This article focuses on new findings leading to improved understanding of the pathophysiology and mechanisms of potential drug interactions between anesthetic drugs or techniques and cardiovascular medications in patients scheduled for surgery. Only the most frequently used drugs are reviewed. Elective surgery provides the luxury to consider these risks and alter therapy accordingly. Under urgent circumstances, however, the increased risks associated with these agents should be anticipated with the goal to minimize adverse effects while maintaining optimal cardiovascular function in the perioperative period. |
| Keywords: | clinical trial; review; drug potentiation; drug withdrawal; side effect; treatment planning; preoperative care; preoperative evaluation; medical decision making; aprotinin; unindexed drug; bleeding; propofol; furosemide; patient monitoring; risk assessment; hyperkalemia; hypotension; disease severity; kidney function; intraoperative period; acetylsalicylic acid; thrombosis; clopidogrel; heparin; systolic blood pressure; perioperative period; drug metabolism; drug half life; heart arrhythmia; hemodynamic monitoring; drug contraindication; beta adrenergic receptor blocking agent; calcium channel blocking agent; captopril; dipeptidyl carboxypeptidase inhibitor; verapamil; diuretics; heart output; anti-arrhythmia agents; meta analysis; drug interactions; diuretic agent; heart muscle ischemia; heart surgery; heart hemodynamics; electrolyte disturbance; risk management; angiotensin receptor antagonist; anesthetics; heart function; anesthesia; drug indication; urine volume; muscle relaxant agent; drug choice; pulmonary hypertension; anesthetic agent; enalapril; hypovolemia; aminocaproic acid; tranexamic acid; adrenergic alpha-agonists; anesthesia induction; angiotensin-converting enzyme inhibitors; platelet aggregation inhibitors; sufentanil; inhalation anesthetic agent; antifibrinolytic agent; cardiovascular agents; adrenergic beta-antagonists; tirofiban; calcium channel blockers; nitroprusside sodium; ticlopidine; abciximab; humans; human; esophagus spasm; heart rate variability; antifibrinolytic agents; alpha adrenergic receptor stimulating agent; enflurane; eptifibatide; esmolol; brain vasospasm; essential hypertension; inotropism; rebound |
| Journal Title: | Heart Disease |
| Volume: | 5 |
| Issue: | 1 |
| ISSN: | 1521-737X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2003-01-01 |
| Start Page: | 34 |
| End Page: | 48 |
| Language: | English |
| PUBMED: | 12549987 |
| PROVIDER: | scopus |
| DOI: | 10.1097/01.HDX.0000050410.54258.24 |
| DOI/URL: | |
| Notes: | Export Date: 25 September 2014 -- Source: Scopus |
